Bristol-Myers agrees to buy ZymoGenetics for $885M
Source: The Seattle Times
Wednesday 8th September, 2010
Bristol-Myers Squibb Co. said Tuesday it will acquire biotechnology partner ZymoGenetics Inc. for $885 million in another move by a major drugmaker to boost its pipeline by snapping up a smaller devel... ...
Read the full story at
The Seattle Times
Email this story to a friend
Have your say on this story